| Neuronal norepinephrine responses of the rostral ventrolateral medulla and nucleus tractus solitarius neurons distinguish the I1- from the alpha2-receptor-mediated hypotension in conscious SHRs. | |
| | |
MedLine Citation:
|
PMID: 15965355 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We tested the hypothesis that the I1 receptor mediates the reduction in rostral ventrolateral medulla (RVLM) neuronal norepinephrine (NE; index of sympathetic activity) that leads to hypotension independent of other brainstem areas or the alpha2-adrenergic receptor. To this end, we developed a model that permitted measurement of real-time changes in neuronal NE in the RVLM or nucleus tractus solitarius (NTS) along with blood pressure and heart rate in the conscious SHR in response to localized microinjections of selective I1 (rilmenidine) or alpha2-adrenergic (alpha-methylnorepinephrine; alpha-MNE) agonist versus the mixed I1/alpha2 agonist clonidine. To further support the hypothesis, we investigated the effects of localized selective alpha2- (SK&F86466) or I1 (efaroxan) blockade on the reductions in neuronal NE and blood pressure elicited by intra-RVLM rilmenidine. In the latter experiment, changes in RVLM neuronal c-Fos (another marker of sympathetic neural activity) were also investigated. Intra-RVLM rilmenidine (40 nmol) or clonidine (1 nmol) similarly reduced RVLM NE and blood pressure; these responses were approximately 2-fold greater than those elicited by the pure alpha2-adrenergic agonist alpha-MNE (10 nmol). By contrast, intra-NTS rilmenidine or clonidine had no effect on NTS NE or blood pressure versus significant reductions in both parameters by alpha-MNE. Intra-RVLM rilmenidine decreased c-Fos expression, and these responses were abolished by efaroxan but not by SK&F 86466. These findings suggest: (1) in the RVLM, I1-receptor signaling suppresses cardiovascular neuron activity, which leads to lowering of blood pressure; (2) although the alpha2-adrenergic receptor in the RVLM serves a similar role, it does not exert a tonic neuronal inhibitory effect and is not essential, as a downstream signaling entity, for the I1-evoked neurobiological effects in the brainstem. The potential confounding effects of anesthetics on the I1 and/or alpha2 receptor-mediated neuronal and cardiovascular responses were circumvented in the present study. |
| | |
Authors:
|
Guichu Li; Xu Wang; Abdel A Abdel-Rahman |
Related Documents
:
|
1737075 - Noradrenergic function in panic disorder. effects of intravenous clonidine pretreatment... 7046065 - Clonidine hydrochloride. 8069405 - Expression of beta-adrenoceptors on circulating mononuclear cells in hypertensives and ... 2469405 - Effects of alpha-adrenoceptor agonists on cardiac output and blood pressure in spinally... 8092505 - Transesophageal echocardiographic monitoring of preoperative acute hypervolemic hemodil... 3698215 - Functional characteristics of intramyocardial capacitance vessels during diastole in th... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Journal of cardiovascular pharmacology Volume: 46 ISSN: 0160-2446 ISO Abbreviation: J. Cardiovasc. Pharmacol. Publication Date: 2005 Jul |
Date Detail:
|
Created Date: 2005-06-20 Completed Date: 2006-05-22 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 7902492 Medline TA: J Cardiovasc Pharmacol Country: United States |
Other Details:
|
Languages: eng Pagination: 52-62 Citation Subset: IM |
Affiliation:
|
Department of Pharmacology, Brody School of Medicine, Greenville, North Carolina 27858-4353, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic alpha-Agonists
/
pharmacology Adrenergic alpha-Antagonists / pharmacology Animals Area Postrema / drug effects, metabolism* Benzazepines / pharmacology Benzofurans / pharmacology Blood Pressure / drug effects Clonidine / pharmacology Consciousness Heart Rate / drug effects Hypotension / physiopathology* Imidazoles / pharmacology Interleukin-1 / pharmacology* Male Motor Activity / drug effects, physiology Neurons / cytology, metabolism Nordefrin / pharmacology Norepinephrine / metabolism* Oxazoles / pharmacology Rats Rats, Inbred SHR Receptors, Adrenergic, alpha-2 / agonists, antagonists & inhibitors, physiology* Solitary Nucleus / drug effects, metabolism* |
| Grant Support | |
ID/Acronym/Agency:
|
AA07839/AA/NIAAA NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic alpha-Agonists; 0/Adrenergic alpha-Antagonists; 0/Benzazepines; 0/Benzofurans; 0/Imidazoles; 0/Interleukin-1; 0/Oxazoles; 0/Receptors, Adrenergic, alpha-2; 4205-90-7/Clonidine; 51-41-2/Norepinephrine; 54187-04-1/rilmenidine; 6539-57-7/Nordefrin; 73943-10-9/benalfocin; 89197-32-0/efaroxan |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Edaravone prevented deteriorated cardiac function after myocardial ischemia-reperfusion via inhibiti...
Next Document: Effects of the long-term administration of nicorandil on vascular endothelial function and the progr...